Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis

Completed · Phase 4 · Has a placebo group

Conditions studied: Rheumatoid Arthritis

In brief

To compare the effects of the combination of ETN and MTX to MTX alone on radiographic change and clinical disease activity in subjects with early RA over 12 months.

Key facts

Study ID

NCT00195494

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

542

Starts

2004-11-01

Expected to finish

2008-03-01

Last updated by the study team

2012-09-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Satisfies the 1987 ACR Revised Criteria for Rheumatoid Arthritis
• Has RA greater than or equal to 3 months and less than or equal to 2 years

You may not qualify if…

• Received any previous treatment with MTX
• Received any previous treatment with ETN or other tumour necrosis factor antagonist

Where it is running

• Study site — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.